Hot--melt extrusion has a significant poten5al as con5nuous produc5on process within the pharmaceu5cal industry. It is an efficient technique for the development of solid dispersions and has been demonstrated to provide products allowing sustained, modified and targeted drug delivery, resul5ng in improved bioavailability.
MATERIALS AND METHODS

Materials
-
Mul>variate Data Analysis
--SIMCA P+ 12.0.1.0 (Umetrics) solid state during a pharmaceu5cal hot--melt extrusion process.
Today, extruders allow in--line monitoring and control of the barrel and die temperature, the melt pressure, the feed rate, the screw speed and the motor load. These parameters are all inherent to the hot--melt extrusion equipment. In--line monitoring and control of quality parameters, such as drug load and solid state, will increase understanding of product behaviour during extrusion and allow real--5me product quality evalua5on. Hence, 5me--consuming off--line analyses acer processing might become unnecessary. 2. In--line solid state monitoring The results of this study demonstrate that Raman spectroscopy can be used for the in--line and real--5me determina5on of the API--concentra5on and the solid state of the polymer--drug melt during hot--melt extrusion. Raman spectroscopy allows detec5on of changes in concentra5on as well as in composi5on of the melt during processing. The in--line collected Raman spectra also gave an indica5on on the intermolecular interac5ons during the hot--melt extrusion process, which leads to a bejer understanding of the process.
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• DSC results ( • Fig. 4 shows 2 important observa5ons in the in--line collected Raman spectra: --MPT peaks become broader and less sharp → transi5on from the crystalline to the amorphous form --Peak shics between physical mixtures and extrudates → interac5ons between Eudragit ® RS PO and MPT during extrusion (most likely hydrogen bonds)
• The broadening and peak shics are larger in mixture A than in mixture B: All MPT in extruded mixture A is amorphous, forming a solid solu5on, whereas in extruded mixture B, some of the MPT remains crystalline. The extrudate of mixture B is a solid dispersion. • The 150 - 50cm --1 region of the Raman spectrum contains informa5on about the crystal structure (Fig. 5 ).
-Pure MPT and the extrudate of mixture B: sharp, well defined peaks → crystalline MPT --Extrudate of mixture A: peaks disappear → amorphous MPT
• PCA: first principle component captures 97% of spectral varia5on, caused by differences in MPT concentra5on (Fig. 2) • PLS: regression of in--line collected Raman spectra (X) versus MPT concentra5on (Y)
Evalua5on of predic5ve performance with 20 test spectra of each mixture and 20 spectra of a 25% (w/w) mixture → RMSEP = 0.59% (Fig. 3) 
